Venus Remedies Limited (VENUSREM) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Venus Remedies Limited (VENUSREM) has a cash flow conversion efficiency ratio of 0.136x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs811.10 Million ≈ $8.77 Million USD) by net assets (Rs5.94 Billion ≈ $64.27 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Venus Remedies Limited balance sheet quality to measure how much of total assets are equity-financed.
Venus Remedies Limited - Cash Flow Conversion Efficiency Trend (2006–2025)
This chart illustrates how Venus Remedies Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Venus Remedies Limited cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Venus Remedies Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Venus Remedies Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Kardemir Karabuk Demir Celik Sanayi ve Ticaret AS Class A
IS:KRDMA
|
0.031x |
|
Sern Kou Resources Bhd
KLSE:7180
|
-0.021x |
|
Jiangsu Smartwin Electronics Technology Co.Ltd.
SHE:301106
|
N/A |
|
First Internet Bancorp
NASDAQ:INBK
|
0.209x |
|
Kumho Ind
KO:002990
|
0.071x |
|
Cint Group AB
ST:CINT
|
0.036x |
|
Rxsight Inc
NASDAQ:RXST
|
-0.041x |
|
Vecima Networks Inc.
TO:VCM
|
0.092x |
Annual Cash Flow Conversion Efficiency for Venus Remedies Limited (2006–2025)
The table below shows the annual cash flow conversion efficiency of Venus Remedies Limited from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see VENUSREM stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs5.61 Billion ≈ $60.66 Million |
Rs909.20 Million ≈ $9.83 Million |
0.162x | +111.94% |
| 2024-03-31 | Rs4.88 Billion ≈ $52.73 Million |
Rs372.85 Million ≈ $4.03 Million |
0.076x | -3.87% |
| 2023-03-31 | Rs4.60 Billion ≈ $49.78 Million |
Rs366.20 Million ≈ $3.96 Million |
0.080x | -14.55% |
| 2022-03-31 | Rs4.40 Billion ≈ $47.63 Million |
Rs410.01 Million ≈ $4.43 Million |
0.093x | -71.90% |
| 2021-03-31 | Rs4.00 Billion ≈ $43.29 Million |
Rs1.33 Billion ≈ $14.34 Million |
0.331x | +39.12% |
| 2020-03-31 | Rs3.23 Billion ≈ $34.97 Million |
Rs770.10 Million ≈ $8.33 Million |
0.238x | +74.71% |
| 2019-03-31 | Rs3.33 Billion ≈ $35.96 Million |
Rs453.27 Million ≈ $4.90 Million |
0.136x | -4.09% |
| 2018-03-31 | Rs3.62 Billion ≈ $39.14 Million |
Rs514.36 Million ≈ $5.56 Million |
0.142x | -35.64% |
| 2017-03-31 | Rs4.52 Billion ≈ $48.84 Million |
Rs997.24 Million ≈ $10.78 Million |
0.221x | +106.13% |
| 2016-03-31 | Rs4.38 Billion ≈ $47.33 Million |
Rs468.81 Million ≈ $5.07 Million |
0.107x | -27.85% |
| 2015-03-31 | Rs4.57 Billion ≈ $49.39 Million |
Rs678.05 Million ≈ $7.33 Million |
0.148x | +30.18% |
| 2014-03-31 | Rs4.62 Billion ≈ $49.92 Million |
Rs526.46 Million ≈ $5.69 Million |
0.114x | -17.09% |
| 2013-03-31 | Rs3.79 Billion ≈ $41.00 Million |
Rs521.50 Million ≈ $5.64 Million |
0.138x | +1.44% |
| 2012-03-31 | Rs3.07 Billion ≈ $33.23 Million |
Rs416.70 Million ≈ $4.51 Million |
0.136x | -13.98% |
| 2011-03-31 | Rs2.37 Billion ≈ $25.62 Million |
Rs373.47 Million ≈ $4.04 Million |
0.158x | -14.83% |
| 2010-03-31 | Rs1.71 Billion ≈ $18.51 Million |
Rs316.83 Million ≈ $3.43 Million |
0.185x | +35.37% |
| 2009-03-31 | Rs1.39 Billion ≈ $14.99 Million |
Rs189.50 Million ≈ $2.05 Million |
0.137x | -36.02% |
| 2008-03-31 | Rs889.86 Million ≈ $9.62 Million |
Rs190.17 Million ≈ $2.06 Million |
0.214x | -50.89% |
| 2007-03-31 | Rs551.31 Million ≈ $5.96 Million |
Rs239.88 Million ≈ $2.59 Million |
0.435x | +58.20% |
| 2006-03-31 | Rs318.96 Million ≈ $3.45 Million |
Rs87.73 Million ≈ $948.76K |
0.275x | -- |
About Venus Remedies Limited
Venus Remedies Limited engages in the pharmaceutical business in India and internationally. It is involved in the research and development of solutions focusing on antimicrobial resistance and oncology. The company also offers analgesic, analgesic and antipyretic, antibiotic, anticoagulant, antiemetic, antiviral, cardiovascular, disinfectant and antiseptic, gastro therapy, hepatoprotective, hormo… Read more